AI Visibility Scorecard
Syklomics Biotechnology — Precision Drug Discovery for Hemoglobinopathies
syklomics.com · Technology
At 0.6/10, Syklomics Biotechnology — Precision Drug Discovery for Hemoglobinopathies is close to invisible in AI search today. Most assistants will not cite it when asked about your category - fixable, and the signals below show exactly where to start.
AI engines read this profile 1 times
Claude
#2,478,156 of 2,706,211 in Technology for AI visibility
0
AI Naming Predictability
iRarely named · 0/100
More likely to be named than 12% of Technology companies
1
AEO Visibility
iNear-invisible · 0.6/10
0
Muse Index Score
iAI agent readiness
Not agent-ready · 0/100
0
AI Adoption
iNone detected · 0/100
About Syklomics Biotechnology — Precision Drug Discovery for Hemoglobinopathies
from our crawl and measurement
Syklomics Biotechnology — Precision Drug Discovery for Hemoglobinopathies describes itself simply: "A multi-omics platform accelerating therapy development for sickle cell disease, built by someone who lives with it." To AI engines like ChatGPT and Perplexity it is close to invisible, scoring 0.6 out of 10.
Under the hood there is a readable heading structure and substantial page content, but the score is capped by what is missing: structured data describing the business, an llms.txt file, a sitemap.
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Weak
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Fair
Experience, Expertise, Authority, Trust markers.
Technical AEO
Fair
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Fair
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 0.6/10, Syklomics Biotechnology — Precision Drug Discovery for Hemoglobinopathies is crawlable but under-signaled - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for Syklomics Biotechnology — Precision Drug Discovery for Hemoglobinopathies
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
Why your brand doesn't show up in ChatGPT answers (and how to fix it)
ChatGPT doesn't crawl the web like Google does. When someone asks Claude about the best project management tools, the model isn't searching your website in real-time. It's pulling from training data that stopped months or years ago.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Syklomics Biotechnology — Precision Drug Discovery for Hemoglobinopathies.
Source & Attribution
Scored by Engagemii on July 31, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/syklomics
Cite this score: Engagemii (2026). "AEO Score for Syklomics Biotechnology — Precision Drug Discovery for Hemoglobinopathies." Retrieved from https://engagemii.com/aeo/brands/syklomics
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform